{"url":"https://lda.gov/api/v1/filings/7b4fb259-112c-45e6-b2e2-68dd93f767e2/","filing_uuid":"7b4fb259-112c-45e6-b2e2-68dd93f767e2","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/7b4fb259-112c-45e6-b2e2-68dd93f767e2/print/","filing_document_content_type":"text/html","income":"15000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Mimi Braniff","dt_posted":"2026-07-01T11:24:21-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"601 13th Street NW, 12th floor","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":401110720,"url":"https://lda.gov/api/v1/registrants/401110720/","house_registrant_id":null,"name":"MAD GLOBAL STRATEGY","description":null,"address_1":"601 13th Street NW, 12th floor","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MIMI BRANIFF","contact_telephone":"+1 202-256-3477","dt_updated":"2026-08-28T15:32:16.171204-04:00"},"client":{"id":73661,"url":"https://lda.gov/api/v1/clients/73661/","client_id":73661,"name":"ADNEURIS THERAPEUTICS, INC.","general_description":"biopharmaceutical company","client_government_entity":null,"client_self_select":false,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2026-06-09"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Education on new drug seeking FDA approval","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":154069,"prefix":null,"prefix_display":null,"first_name":"MIMI","nickname":null,"middle_name":null,"last_name":"BRANIFF","suffix":null,"suffix_display":null},"covered_position":"Senate Energy Committee- Special Counsel; Senate Commerce Committee- Deputy Chief Counsel; Senate Appropriations Committee- Counsel; Senator Ted Stevens- Legislative Assistant","new":false}],"government_entities":[{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}